Inactive Ingredients Exemption From Labeling Rule Sought By Zee Medical
This article was originally published in The Tan Sheet
Executive Summary
Zee Medical is seeking FDA exemption from OTC labeling rule requirements that each inactive ingredient be listed on a product. In a Sept. 15 application, the company requests it be "allowed to use the phrase 'may contain' to list inactive ingredients that may or may not be present" in its PainAid Pain Relief tablets.
You may also be interested in...
Bactec Kit Outer Labeling Only Required To Comply With “Drug Facts” Format
The individual OTC components in Becton Dickinson's Bactec Blood Culture Procedural Tray will not be required to carry "Drug Facts" labeling as long as the kit's outer package uses the OTC labeling format to describe the components, FDA says in a June 5 letter to the firm
Bactec Kit Outer Labeling Only Required To Comply With “Drug Facts” Format
The individual OTC components in Becton Dickinson's Bactec Blood Culture Procedural Tray will not be required to carry "Drug Facts" labeling as long as the kit's outer package uses the OTC labeling format to describe the components, FDA says in a June 5 letter to the firm
Bactec Kit Outer Labeling Only Required To Comply With “Drug Facts” Format
The individual OTC components in Becton Dickinson's Bactec Blood Culture Procedural Tray will not be required to carry "Drug Facts" labeling as long as the kit's outer package uses the OTC labeling format to describe the components, FDA says in a June 5 letter to the firm